Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119

NCT06504290 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: VV119 Placebo （in healthy adult subjects）
DRUG: VV119 （in healthy adult subjects）
DRUG: VV119(in adult patients with schizophrenia)
DRUG: VV119 Placebo （in adult patients with schizophrenia）

Sponsor

Vigonvita Life Sciences